Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index (Q44705970)

5 December 2017

Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index (English)

1 reference

5 December 2017

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Luc R Desnoyers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Olga Vasiljeva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jennifer H Richardson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Annie Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Elizabeth E M Menendez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Tony W Liang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Chihunt Wong

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paul H Bessette

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Kathy Kamath

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Stephen J Moore

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jason G Sagert

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Daniel R Hostetter

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Fei Han

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jason Gee

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jeanne Flandez

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Kate Markham

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Michael Krimm

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Kenneth R Wong

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Shouchun Liu

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Patrick S Daugherty

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

James W West

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Henry B Lowman

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

1 October 2013

1 reference

Science Translational Medicine

5 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

207ra144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132639%20AND%20SRC:MED&resulttype=core&format=json

Paul Ehrlich's magic bullet concept: 100 years of progress.

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Marketed therapeutic antibodies compendium

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Antibody-drug conjugate targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Trastuzumab--mechanism of action and use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Trastuzumab emtansine for HER2-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

ErbB receptors and signaling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

The safety and side effects of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

State of the art in tumor antigen and biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Bacterial display using circularly permuted outer membrane protein OmpX yields high affinity peptide ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Inflammation, proteases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Protease specificity determination by using cellular libraries of peptide substrates (CLiPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

The urokinase plasminogen activator system: a target for anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Matriptase and its putative role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Imaging a functional tumorigenic biomarker in the transformed epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682

Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006682